These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7619678)

  • 21. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group.
    Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
    Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin. The Quality of Life Multicenter Group.
    Weir MR; Berger ML; Weeks ML; Liss CL; Santanello NC
    Am J Cardiol; 1996 Mar; 77(7):475-9. PubMed ID: 8629587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.
    McDowell IF; Smye M; Trinick T; Shortt JA; Archibald MP; Trimble ER; Nicholls DP
    Br J Clin Pharmacol; 1991 Mar; 31(3):340-3. PubMed ID: 2054273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pravastatin and simvastatin for hypercholesterolemia.
    Med Lett Drugs Ther; 1991 Mar; 33(839):18-20. PubMed ID: 1899899
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin in non-insulin-dependent diabetic patients with hypercholesterolaemia.
    Steyn K; Weich HF; Bonnici F; Kotze TJ; Stander I; Vermaak WJ; Lourens W; van Lathem J; Omar MA; Fourie J
    S Afr Med J; 1992 Dec; 82(6):402-6. PubMed ID: 1465688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance.
    Gengo F; Cwudzinski D; Kinkel P; Block G; Stauffer L; Lines C
    Clin Cardiol; 1995 Apr; 18(4):209-14. PubMed ID: 7788948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of new drugs for lowering plasma cholesterol concentrations.
    Illingworth DR
    Drugs; 1991 Feb; 41(2):151-60. PubMed ID: 1709846
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).
    Bestehorn HP; Rensing UF; Roskamm H; Betz P; Benesch L; Schemeitat K; Blümchen G; Claus J; Mathes P; Kappenberger L; Wieland H; Neiss A
    Eur Heart J; 1997 Feb; 18(2):226-34. PubMed ID: 9043838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
    Alessandri C; Peverini F
    Minerva Med; 1992 Nov; 83(11):677-93. PubMed ID: 1461539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM; Thompson GR
    Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and dementia.
    Golomb BA; Jaworski B
    Arch Neurol; 2001 Jul; 58(7):1169-70. PubMed ID: 11448316
    [No Abstract]   [Full Text] [Related]  

  • 36. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.
    Arnadottir M; Eriksson LO; Germershausen JI; Thysell H
    Nephron; 1994; 68(1):57-62. PubMed ID: 7991041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pravastatin versus simvastatin--what happens in the real world?
    Levenstein S
    S Afr Med J; 1995 May; 85(5):388-91. PubMed ID: 7638696
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.